Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.38 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22996243 | 1.00 | ALDH1A1 (0.52) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL22996224 | 1.00 | ALDH1A1 (0.52) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL22996249 | 1.00 | ALDH1A1 (0.52) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL13915394 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL21076323 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL21076357 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL21076300 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL13915448 | 0.90 | ALDH1A1 (0.43) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| Sulfuric Acid SCHEMBL9359044 | 0.89 | ALDH1A1 (0.44) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL27548165 | 0.89 | ALDH1A1 (0.43) | ALDH1A1KDM4EKMT2ALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 614 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4452210-B1 | DYEING METHOD FOR KERATIN FIBERS COMPRISING A DIRECT AZO-DYE AND AN ORGANIC ALKALIZING AGENT, AND KIT-OF-PARTS THEREOF | KAO CORP (JP) | 2026-01-14 | — | — | EP | claimed |
| US-12479826-B2 | Pyridazinyl amino derivatives as ALK5 inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2025-11-25 | — | — | US | claimed |
| EP-4182308-B1 | PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS | CHIESI FARM SPA (IT) | 2024-09-04 | — | — | EP | claimed |
| CN-118325568-A | Method for increasing adhesive force of sandwich panel | 江苏逸欣节能科技有限公司 | 2024-07-12 | — | — | CN | claimed |
| US-20240018122-A1 | PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2024-01-18 | — | — | US | claimed |
| EP-3571314-B1 | COMPOSITION AND METHOD OF USE OF THE SAME FOR PRESERVING CELLS FOR ANALYSIS | CHRYOS LLC (US) | 2023-12-20 | — | — | EP | claimed |
| CN-117247989-A | Liquid thrombin time determination reagent and preparation method thereof | 美康生物科技股份有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-117043353-A | Method for detecting microRNA in biological sample, composition of hydrochloride of neutral amino acid and container | 东丽株式会社 | 2023-11-10 | — | — | CN | claimed |
| CN-116875980-A | Copper-reducing additive for HDI board and copper-reducing process | 上海天承化学有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-112501110-B | Standardized culture medium for three-dimensional culture of lung and lung cancer tissue organoids and culture method | 海西纺织新材料工业技术晋江研究院 | 2023-08-25 | — | — | CN | claimed |
| US-7026503-B2 | Method for producing (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-11 | — | — | US | claimed |
| EP-1399408-B1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AG (DE) | 2006-03-22 | — | — | EP | claimed |
| WO-2005109108-A1 | COMPOSITION FOR REMOVING A (PHOTO) RESIST | DONGJIN SEMICHEM CO., LTD. (KR) | 2005-11-17 | — | — | WO | claimed |
| WO-2005109107-A1 | COMPOSITION FOR REMOVING A (PHOTO)RESIST | DONGJIN SEMICHEM CO., LTD. (KR) | 2005-11-17 | — | — | WO | claimed |
| JP-2004513911-A | — | — | 2004-05-13 | — | — | JP | claimed |
| EP-1337234-A1 | USE OF 2-OXOTHIAZOLIDINE 4-CARBOXYLIC ACID DERIVATIVES AS AGENTS PROMOTING SKIN PEELING | L'OREAL (FR) | 2003-08-27 | — | — | EP | claimed |
| EP-1337233-A1 | USE OF AT LEAST A SULPHONIC AMINO DERIVATIVE IN A COMPOSITION PROMOTING SKIN PEELING | L'OREAL (FR) | 2003-08-27 | — | — | EP | claimed |
| WO-2002039975-A1 | USE OF AT LEAST A SULPHONIC AMINO DERIVATIVE IN A COMPOSITION PROMOTING SKIN PEELING | L'OREAL (FR) | 2002-05-23 | — | — | WO | claimed |
| WO-2002039976-A1 | USE OF 2-OXOTHIAZOLIDINE 4-CARBOXYLIC ACID DERIVATIVES AS AGENTS PROMOTING SKIN PEELING | L'OREAL (FR) | 2002-05-23 | — | — | WO | claimed |
| EP-0213734-B1 | Viscoelastic solution | LINDSTROM RICHARD L (US) | 1994-02-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018122-A1 | PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS | ALK, TGFBR1, ACVR1 | ALDH1A1 742/4885KDM4E 474/4885KMT2A 2453/4885 |
| US-12479826-B2 | Pyridazinyl amino derivatives as ALK5 inhibitors | ALK, TGFBR1, ACVR1 | ALDH1A1 742/4885KDM4E 474/4885KMT2A 2453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.